CD4 and neoplasm: Our studies demonstrated that following Mam-A cDNA vaccination, there was an upregulation of tumor lytic CD4+ ICOShi T-cells in Mam-A vaccinated breast cancer patients [34] and also induction of antigen specific CD8+ T-cell effector responses [18].